Gene · 701
Papers3,969
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,969
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive bioinformatics analysis reveals key hub genes linked to prognosis in multiple myeloma with drug resistance. | Medicine (Baltimore) | 2025 | 40068082 | PubTator, text mining | PubMed |
| BUB1B promotes cisplatin resistance in gastric cancer via Rad51-mediated DNA damage repair. | Transl Oncol | 2025 | 40056529 | PubTator, text mining | PubMed |
| BubR1 Controls Heart Development by Promoting Expression of Cardiogenesis Regulators. | J Am Heart Assoc | 2025 | 40055864 | PubTator, text mining | PubMed |
| Pathogenic variants of BUB1 and BUBR1 genes are not prioritized in screening tests of couples with aborted aneuploid fetuses. | Mol Biol Res Commun | 2025 | 40028477 | PubTator, text mining | PubMed |
| Targeting the AURKB-MAD2L2 Axis Disrupts the DNA Damage Response and Glycolysis to Inhibit Colorectal Cancer Progression. | Front Biosci (Landmark Ed) | 2025 | 40018943 | PubTator, text mining | PubMed |
| Design and synthesis of novel HDAC6 inhibitor dimer as HDAC6 degrader for cancer treatment by palladium catalysed dimerisation. | J Enzyme Inhib Med Chem | 2025 | 40013582 | PubTator, text mining | PubMed |
| Chemokines and PI3K/AKT signaling pathway mediate the spontaneously ruptured hepatocellular carcinoma through the regulation of the cell cycle. | Hepatobiliary Pancreat Dis Int | 2025 | 39952875 | PubTator, text mining | PubMed |
| Identification of Novel lncRNAs Related to Colorectal Cancer Through Bioinformatics Analysis. | Biomed Res Int | 2025 | 39949372 | PubTator, text mining | PubMed |
| Integrative Bioinformatics Analysis for Targeting Hub Genes in Hepatocellular Carcinoma Treatment. | Curr Genomics | 2025 | 39911278 | PubTator, text mining | PubMed |
| Chromosome Missegregation Triggers Tumor Cell Pyroptosis and Enhances Anti-Tumor Immunotherapy in Colorectal Cancer. | Adv Sci (Weinh) | 2025 | 39903759 | PubTator, text mining | PubMed |
| Exploring the mechanism and drug candidates of alveolar echinococcosis affecting liver fibrosis through analysis of existing microarray data. | Acta Trop | 2025 | 39863141 | PubTator, text mining | PubMed |
| Identification of potential biomarkers for 2022 Mpox virus infection: a transcriptomic network analysis and machine learning approach. | Sci Rep | 2025 | 39848951 | PubTator, text mining | PubMed |
| Synthesis and biological assessment of BUB1B inhibitors for the treatment of clear cell renal cell carcinoma. | Eur J Med Chem | 2025 | 39818011 | PubTator, text mining | PubMed |
| The miRNA-mRNA Regulatory Network in Human Hepatocellular Carcinoma by Transcriptomic Analysis From GEO. | Cancer Rep (Hoboken) | 2025 | 39764737 | PubTator, text mining | PubMed |
| Aneuploidy-driven gene expression profiling in human blastocysts: insights from RNA-Seq analysis. | J Assist Reprod Genet | 2025 | 39753942 | PubTator, text mining | PubMed |
| FRET-FLIM for the Study of Protein-Protein Interactions Underpinning Mitosis Checkpoints. | Methods Mol Biol | 2025 | 39614049 | PubTator, text mining | PubMed |
| Evaluation of BUBR1, MCM2, and GMNN as oral cancer biomarkers. | Eur J Cancer Prev | 2025 | 39480819 | PubTator, text mining | PubMed |
| Identification of novel candidate predisposing genes in familial nonmedullary thyroid carcinoma implicating DNA damage repair pathways. | Int J Cancer | 2025 | 39251783 | PubTator, text mining | PubMed |
| Identification of MAD2L1 and BUB1B as Potential Biomarkers Associated with Progression and Prognosis of Ovarian Cancer. | Biochem Genet | 2025 | 38683465 | PubTator, text mining | PubMed |
| Ras-dependent activation of BMAL2 regulates hypoxic metabolism in pancreatic cancer. | bioRxiv | 2025 | 36993718 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/701/papers?page=8